Evidence map›Paper›PMID 36317053›Full record

ArticleCommunications medicine2022

Leo M Schouls, Kees Veldman, Michael S M Brouwer, Cindy Dierikx, Sandra Witteveen, Marga van Santen-Verheuvel, Antoni P A Hendrickx, Fabian Landman, Paul Hengeveld, Bart Wullings and 4 more

Open access · goldAbstract read
In one paragraph

Article in Communications medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.9field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Microorganisms · 2025
    Review
  5. Article
  6. Article
  7. Genomic Analyses of Methicillin-ResistantAntibiotics (Basel, Switzerland) · 2024
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Genomics Insight intoAntibiotics (Basel, Switzerland) · 2023
    Article
  16. The prevalence ofFrontiers in microbiology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 20 institutions in 1 country.

Leo M SchoulsNational Institute for Public Health and the Environment (RIVM), Infectious Diseases Research, Diagnostics and laboratory Surveillance (IDS), Bilthoven, The Netherlands.ORCID 0000-0003-1253-9794
Kees VeldmanWageningen Bioveterinary Research (WBVR), Bacteriology, Host Pathogen Interaction & Diagnostics, Lelystad, The Netherlands.ORCID 0000-0002-2560-3276
Michael S M BrouwerWageningen Bioveterinary Research (WBVR), Bacteriology, Host Pathogen Interaction & Diagnostics, Lelystad, The Netherlands.ORCID 0000-0002-1067-7555
Cindy DierikxNational Institute for Public Health and the Environment (RIVM), Zoonoses and Environmental Microbiology (Z&O), Bilthoven, The Netherlands.
Sandra WitteveenNational Institute for Public Health and the Environment (RIVM), Infectious Diseases Research, Diagnostics and laboratory Surveillance (IDS), Bilthoven, The Netherlands.
Marga van Santen-VerheuvelNational Institute for Public Health and the Environment (RIVM), Infectious Diseases Research, Diagnostics and laboratory Surveillance (IDS), Bilthoven, The Netherlands.
Antoni P A HendrickxNational Institute for Public Health and the Environment (RIVM), Infectious Diseases Research, Diagnostics and laboratory Surveillance (IDS), Bilthoven, The Netherlands.ORCID 0000-0003-4431-9323
Fabian LandmanNational Institute for Public Health and the Environment (RIVM), Infectious Diseases Research, Diagnostics and laboratory Surveillance (IDS), Bilthoven, The Netherlands.ORCID 0000-0001-6543-836X
Paul HengeveldNational Institute for Public Health and the Environment (RIVM), Zoonoses and Environmental Microbiology (Z&O), Bilthoven, The Netherlands.
Bart WullingsWageningen Food Safety Research, Team Bacteriology, Molecular Biology & AMR, Wageningen, The Netherlands.
Michel RapalliniWageningen Food Safety Research, Team Bacteriology, Molecular Biology & AMR, Wageningen, The Netherlands.
Ben WitNetherlands Food and Consumer Product Safety Authority (NVWA), Food safety, Apeldoorn, The Netherlands.
Engeline van DuijkerenNational Institute for Public Health and the Environment (RIVM), Zoonoses and Environmental Microbiology (Z&O), Bilthoven, The Netherlands.ORCID 0000-0002-9419-9852
Dutch MRSA surveillance study group
National Institute for Public Health and the Environment · NLWageningen University & Research · NLAlrijne Ziekenhuis · NLAmsterdam UMC Location University of Amsterdam · NLCanisius-Wilhelmina Ziekenhuis · NLCerte · NLDiakonessenhuis hospital · NLErasmus MC · NLGelre Hospitals · NLIkazia Ziekenhuis · NLMaastricht University Medical Centre · NLNoordwest Ziekenhuisgroep · NLOmring · NLRadboud University Nijmegen · NLReinier de Graaf Hospital · NLSlingeland Ziekenhuis · NLUniversity Medical Center Groningen · NLZiekenhuis Groep Twente · NLAdmiraal De Ruyter Ziekenhuis · NLAlbert Schweitzer Ziekenhuis · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Although the Netherlands is a country with a low endemic level of methicillin-resistant Methods: The sequenced genomes of 6327 MRSA surveillance isolates from humans and from 332 CC398 isolates from livestock-related samples were analyzed and resistance genes were identified. Several isolates were subjected to long-read sequencing to reconstruct chromosomes and plasmids. Results: Here we show the presence of the multi-resistance gene Conclusions: The rare

Indexed as

EpidemiologyInfectious-disease epidemiology

Identifiers

PMID36317053
PMCPMC9616846
OpenAlexW4307952888

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.